
FutureScripts was proud to partner with Independence Blue Cross (IBC) in administering its ground-breaking No Pay Copay program. Lasting all of 2007, No Pay Copay touted the safety and cost-saving benefits of generic drugs to IBC members. With the program finished, IBC and FutureScripts encourage plan participants to continue to save money by getting into the habit of always asking for generics first.
Thanks to No Pay Copay, IBC members saved nearly $50 million in waived copays in 2007. During this time, the use of generics among IBC members increased from 52.1 percent to 60 percent.
A survey* showed plan participants not only thought highly of No Pay Copay, but of generic drugs in general.
FutureScripts encourages its plan participants to consider asking for generic drugs, which can cost up to 70 percent less than their brand-name counterparts. Generic drugs are always the lowest copay amount on the FutureScripts formulary. Actual copay amounts vary, depending on the plan and administrator.
* The IBC survey was conducted by DSS Research, a national health care research firm headquartered in Fort Worth, Texas. In September 2007, 805 adult IBC members in the southeastern Pennsylvania five-county area were interviewed for this survey. The margin of error on the overall sample was +/- 3.5 percent.